The Impact of Substantial Improvements in HbA1c and Weight Loss on the Medication Preferences of People with Type 2 Diabetes
The prevalence of diabetes has been increasing worldwide for the past several decades, reaching over 37 million people in the US and approximately five million people in the UK. Over...
Conclusion: HbA1c reduction, frequency of hypoglycemia, and weight reduction are key drivers of preferences among people with T2D when considering medication options. Overall, people with T2D are likely to prefer the tirzepatide over the semaglutide 1mg medication profiles.
Systematic Review and Meta-Analysis of the Impact of Bariatric Surgery on Future Cancer Risk - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/37047163/
The study aimed to perform a systematic review and meta-analysis of the evidence for the prevention of future cancers following bariatric surgery. A systematic literature search of the Cochrane Library,...
Conclusions/Relevance: Bariatric surgery results in long-term weight loss in morbidly obese patients and improves metabolic syndrome. Bariatric surgery may decrease future overall cancer incidence and mortality, including the incidence of seven obesity-related cancers.
Acute pharmacodynamic responses to exenatide: Drug-induced increases in insulin secretion and glucose effectiveness
Source : https://www.medrxiv.org/content/10.1101/2023.03.15.23287166v1
Background GLP1R agonists provide multiple benefits to patients with type 2 diabetes - including improved glycemic control, weight loss, and decreased risk of major adverse cardiovascular events. Because drug responses...
Conclusions: This pilot study provides validation for the value of an FSIGT (including minimal model analysis) to provide primary data for our ongoing pharmacogenomic study of pharmacodynamic effects of semaglutide. Three endpoints provide quantitative assessments of GLP1R agonist effects on glucose metabolism: first phase insulin...
Dermal Hypersensitivity Reaction to Semaglutide: Two Case Reports - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/37026881/
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of antidiabetic agents that work by inducing insulin secretion and inhibiting release of glucagon in a glucose-dependent manner. They are especially promising...
Relevance: In the first case, a 75-year-old woman who had been taking semaglutide for 10 months presented with an eruption on her legs, back, and chest for 3 months duration. Histology showed a subepidermal blister with eosinophils, suggestive of a drug hypersensitivity reaction. In the second case, a 74-year-old white man who had been...
Microbiota-gut-brain axis: relationships among the vagus nerve, gut microbiota, obesity, and diabetes - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/37058160/
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site. The site is secure....
Conclusions: Because of its enteroendocrine cell-mediated interaction with the gut microbiota, the vagus nerve may provide a potential pathway through which gut microorganisms influence host feeding behavior and metabolic control of physiological and pathological conditions.
